Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 360 UK biotechnology companies below.
Viral vector platform for solid tumour immunotherapy
Akamis Bio is a clinical-stage oncology company developing oncolytic adenoviral therapeutics for solid tumours. Its platform delivers immunotherapeutic payloads directly to tumour sites following intravenous dosing, enabling tumour-localised expression of proteins including CD40 agonist antibodies and cytokines. Lead…
Lentiviral vector yield enhancement via HDAC inhibitors and producer lines
Synthistat is a biotechnology company developing technologies to increase lentiviral vector production for cell and gene therapy manufacturing. Its work combines designed histone deacetylase (HDAC) inhibitors with approaches to modify HEK293 producer cells. The company has reported early laboratory results from…
ML-guided strain engineering to optimise precision fermentation yields
Eden Genetics is a biotechnology company using machine learning to improve recombinant protein production through microbial strain engineering. Its computational platform analyses genetic and fermentation data to identify modifications intended to increase protein secretion and productivity in precision-fermentation…
Small molecules improving ribosomal translation accuracy in ageing cells
Ribogenyx is a biotechnology company developing small-molecule therapies to improve protein synthesis accuracy in ageing cells. Its approach targets translational fidelity, the accuracy with which ribosomes translate messenger RNA into proteins. By reducing production errors, the company aims to preserve protein…
Synthetic polymer affinity ligands for viral vector bioprocessing
Tozaro is a biotechnology company developing synthetic polymer-based affinity ligands to improve the downstream processing of viral vectors used in cell and gene therapy. Using molecular modelling and machine learning, Tozaro rationally designs polymer-based binders from a chemical space of over 500 monomers, offering…
Preclinical mRNA nanoparticle therapeutics for chronic inflammatory disease
EVolution Therapeutics is a preclinical-stage biotechnology company developing mRNA nanoparticle and hydrogel-based therapeutics to resolve chronic inflammation and support tissue repair. Spun out of Aston University, its platform delivers mRNA encoding pro-resolving proteins directly to sites of disease. The lead…
AI-powered microbiome and phage therapy platform for gut disorders
GutSee Health is a biotechnology company developing precision microbiome therapies for gut disorders including irritable bowel syndrome and inflammatory bowel disease. Its AI discovery platform integrates multi-omics and microbiome data to identify molecular disease signatures and therapeutic targets. A parallel…
Targeting developmentally-silent oncogenic drivers for cancer therapy
Awen Oncology is a Welsh oncology biotechnology company developing first-in-class therapeutics that target cancer-specific proteins derived from developmental genes that are dormant in healthy adult tissue but aberrantly reactivated in tumour cells. The company's platform integrates high-throughput cell and molecular…
Non-invasive oral cancer screening using genomics and cell-free DNA
Wisdom Bioscience is a biotechnology company developing a non-invasive oral cancer screening platform that integrates next-generation sequencing and cell-free DNA analysis with saliva-based sample collection. The platform is designed to enable early detection of oral cancer through routine dental appointments,…
Reproductive genetic testing and embryo screening for fertility clinics
Igenomix UK is a reproductive genetics laboratory providing diagnostic testing services for fertility clinics and reproductive medicine specialists. Its services include preimplantation genetic testing for chromosomal abnormalities and inherited conditions, alongside carrier screening and endometrial assessments. The…
In vivo nanoparticle screening for genetic medicine delivery
Ride Therapeutics is a joint University of Cambridge and Harvard spin-out developing nanoparticle delivery systems for mRNA and gene-editing medicines. Its Molecular Logistics platform engineers and screens large libraries of non-viral carriers in living systems, measuring tissue and cell-type targeting to train an…
Biopharmaceutical group distributing and developing cannabis-based medicines
GROW Group is a biopharmaceutical company focused exclusively on cannabis-based medicines, operating through complementary distribution and research divisions. Its UK distribution arm, Grow Group UK, is a licensed GMP specials manufacturer supplying prescribed cannabinoid medicines to patients via specialist…
Platelet function biomarkers and assays for cardiovascular clinical research
HaemAnalytica is a University of Reading biotechnology spin-out developing platelet-function assays for cardiovascular research and clinical trials. Its TRIPLEcheck platform uses platelet biomarkers to predict thrombotic risk and antiplatelet treatment response. PLANA combines preserved blood samples, flow cytometry…
Coronary plaque biomarkers for precision cardiovascular medicine
PlaqueTec develops a catheter-based liquid biopsy system to investigate biological processes driving coronary artery disease. Its device samples blood at sites around coronary plaques, allowing researchers to compare local concentrations of proteins and other molecules. These data feed its BioCarta platform for…
Primary cell lines and functional ingredients for cultivated meat
Quest Meat is a biotechnology company supplying primary cell lines and developing edible protein ingredients for alternative-protein production. Its catalogue includes bovine, porcine and water buffalo muscle satellite cells and adipose-derived stem cells for cultivated meat research, with quality documents and…
AI platform for in silico antibody discovery
Antiverse is a Cardiff-based company using machine learning to identify diverse and rare antibody candidates from next-generation sequencing data of naïve and immune repertoires. Its AI-augmented discovery platform analyses NGS data in silico to shortlist effective and developable antibodies, claiming a tenfold…
Biopesticides, insect lures and smart traps for sustainable pest management
Razbio is a Welsh biotech company developing sustainable pest management solutions for agriculture and public health. Its product portfolio spans fungal biopesticides, AI-identified insect lures and repellents, and automated AI-equipped smart traps for field pest monitoring. Validated products include a lure for…
Engineered bacteriophages for precision antimicrobial discovery
BioPhoundry is an engineering biology company developing bacteriophage-based technologies for precision antimicrobial research. Its Phax platform combines machine learning, synthetic biology and cell-free production to accelerate phage discovery and engineering. The company aims to generate tailored phages for…
Blood-based microRNA test for multi-cancer early detection
Xgenera is a diagnostics company developing a blood test for the early detection of multiple cancers from a single sample. The test measures circulating microRNA biomarkers using PCR-based methods and applies machine learning to identify signals from up to 12 common cancers before symptoms appear. The company is…
Bacteriophage-integrated antibacterial textiles for surgical implant infection prevention
Oxford Silk Phage Technologies is a biotechnology company developing antibacterial biomaterials that integrate bacteriophages into silk-based medical textiles, for use in surgical implants and wound care devices. The technology embeds high-density cocktails of bacteriophages throughout the textile structure, producing…